Plain-English translation of NCT06564389 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is an early-stage trial testing a new medication called to see if it is safe and well-tolerated. The trial has two parts: first, researchers will test the medication in healthy adults to understand how it works in the body and watch for side effects. Then, they will test it in people with moderate to severe atopic dermatitis (a chronic skin condition causing intense itching and inflammation) to see if the medication helps reduce their symptoms.
Atopic dermatitis is a chronic skin condition that causes significant discomfort and can greatly affect quality of life. Many people do not respond well enough to current treatments, so researchers are looking for new options that might help people with this condition.
You likely qualify if…
You likely don't qualify if…
If you qualify for the healthy volunteer group, you will receive either the new medication or a placebo (a dummy treatment with no active ingredient) in increasing doses and visit the clinic for safety monitoring and blood tests. If you have atopic dermatitis, you will similarly receive either the medication or placebo and attend visits where researchers will examine your skin, take photographs, and monitor how you respond to treatment. The trial involves both single doses and multiple doses given over time, with careful tracking of any side effects.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
United States